Login / Signup

E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester).

Jinfeng XiongSongwei TanLong YuHui ShenShen QuChong ZhangCi RenDa ZhuHui Wang
Published in: International journal of nanomedicine (2021)
Our NPs have great potential to be developed as a drug for the treatment of HPV-related cervical cancer and precancerous lesions.
Keyphrases
  • crispr cas
  • high grade
  • genome editing
  • cancer therapy
  • cervical cancer screening
  • combination therapy
  • climate change
  • adverse drug
  • drug delivery